Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatography

The phthalimidone derivatives EM12 and lenalidomide, which are both structurally related to thalidomide, are highly interesting drugs and very recently lenalidomide attracted great attention as an antitumor and immune-modulating drug [1] in the therapy for multiple myeloma [2]. EM12 and lenalidomide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Walz, Sarah (VerfasserIn) , Weis, Sylvia (VerfasserIn) , Franz, Mareike (VerfasserIn) , Rominger, Frank (VerfasserIn) , Trapp, Oliver (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Electrophoresis
Year: 2014, Jahrgang: 36, Heft: 5, Pages: 796-804
ISSN:1522-2683
DOI:10.1002/elps.201400499
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/elps.201400499
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/elps.201400499
Volltext
Verfasserangaben:Sarah Walz, Sylvia Weis, Mareike Franz, Frank Rominger, Oliver Trapp

MARC

LEADER 00000caa a2200000 c 4500
001 1702838110
003 DE-627
005 20230428073810.0
007 cr uuu---uuuuu
008 200629r20152014xx |||||o 00| ||eng c
024 7 |a 10.1002/elps.201400499  |2 doi 
035 |a (DE-627)1702838110 
035 |a (DE-599)KXP1702838110 
035 |a (OCoLC)1341341769 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 30  |2 sdnb 
100 1 |a Walz, Sarah  |e VerfasserIn  |0 (DE-588)1115004891  |0 (DE-627)869450840  |0 (DE-576)477606377  |4 aut 
245 1 0 |a Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatography  |c Sarah Walz, Sylvia Weis, Mareike Franz, Frank Rominger, Oliver Trapp 
264 1 |c 2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 11 December 2014 
500 |a Gesehen am 29.06.2020 
520 |a The phthalimidone derivatives EM12 and lenalidomide, which are both structurally related to thalidomide, are highly interesting drugs and very recently lenalidomide attracted great attention as an antitumor and immune-modulating drug [1] in the therapy for multiple myeloma [2]. EM12 and lenalidomide are chiral, and the stereogenic carbon C-3 in the piperidine-2,6-dione moiety of these phthalimidone derivatives is prone to interconversion due to keto-enol tautomerization. The knowledge of the enantiomerization barrier [3-47] is mandatory for pharmacokinetic studies and to develop a tailored therapy using the enantiopure or racemic drug. Here, we used dynamic EKC in combination with direct-calculation methods to determine the enantiomerization barriers of EM12 and lenalidomide. The separations of the enantiomers of EM12 and lenalidomide were performed in 50 mM aqueous disodium hydrogen phosphate buffer at pH 8 and 50 mM aqueous sodium tetraborate buffer at pH 9.3, respectively, using 20 mg/mL heptakis-(2,3-diacetyl-6-sulfato)-β-CD as a chiral additive. Enantiomerization of the compounds during the electrokinetic chromatographic separation resulted in pronounced plateau formation between the well-separated enantiomers. Peak form analysis of the experimentally obtained interconversion profiles yielded the enantiomerization rate constants k1 of EM12 and lenalidomide as well as the kinetic activation parameters ΔG‡, ΔH‡‡, and ΔS‡ of enantiomerization by the evaluation of temperature-dependent measurements. The enantiomerization barrier ΔG‡ was determined to be 98.3 ± 1.0 kJ/mol; the activation parameters ΔH‡ = 46.1 ± 2.4 kJ/mol and ΔS‡ = −170 ± 61 J/(K·mol) for EM12 and ΔG‡ = 91.5 ± 1.0 kJ/mol, ΔH‡ = 62.4 ± 5.4 kJ/mol, and ΔS‡ = −98 ± 7 J/(K·mol) for lenalidomide. These findings were corroborated by density functional theory calculations at the B3LYP/3-21G level of theory of the ground state and intermediates considering an enantiomerization pathway via a keto-enol tautomerism. 
534 |c 2014 
650 4 |a Antitumor drug 
650 4 |a Immune-modulating drug 
650 4 |a Racemization 
650 4 |a Revlimid 
650 4 |a Unified equation 
700 1 |a Weis, Sylvia  |d 1985-  |e VerfasserIn  |0 (DE-588)1150442069  |0 (DE-627)1010759795  |0 (DE-576)497073498  |4 aut 
700 1 |a Franz, Mareike  |e VerfasserIn  |4 aut 
700 1 |a Rominger, Frank  |d 1964-  |e VerfasserIn  |0 (DE-588)1019978228  |0 (DE-627)691067821  |0 (DE-576)359202756  |4 aut 
700 1 |a Trapp, Oliver  |d 1973-  |e VerfasserIn  |0 (DE-588)123258634  |0 (DE-627)70623071X  |0 (DE-576)184366003  |4 aut 
773 0 8 |i Enthalten in  |t Electrophoresis  |d Weinheim : Wiley-Blackwell, 1980  |g 36(2015), 5, Seite 796-804  |h Online-Ressource  |w (DE-627)26953878X  |w (DE-600)1475486-1  |w (DE-576)093885946  |x 1522-2683  |7 nnas  |a Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatography 
773 1 8 |g volume:36  |g year:2015  |g number:5  |g pages:796-804  |g extent:9  |a Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatography 
856 4 0 |u https://doi.org/10.1002/elps.201400499  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/elps.201400499  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200629 
993 |a Article 
994 |a 2015 
998 |g 123258634  |a Trapp, Oliver  |m 123258634:Trapp, Oliver  |d 120000  |d 120100  |e 120000PT123258634  |e 120100PT123258634  |k 0/120000/  |k 1/120000/120100/  |p 5  |y j 
998 |g 1019978228  |a Rominger, Frank  |m 1019978228:Rominger, Frank  |d 120000  |d 120100  |e 120000PR1019978228  |e 120100PR1019978228  |k 0/120000/  |k 1/120000/120100/  |p 4 
998 |g 1150442069  |a Weis, Sylvia Sabine  |m 1150442069:Weis, Sylvia Sabine  |p 2 
998 |g 1115004891  |a Walz, Sarah  |m 1115004891:Walz, Sarah  |d 120000  |d 120100  |e 120000PW1115004891  |e 120100PW1115004891  |k 0/120000/  |k 1/120000/120100/  |p 1  |x j 
999 |a KXP-PPN1702838110  |e 3692038194 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatography","title_sort":"Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatography"}],"recId":"1702838110","name":{"displayForm":["Sarah Walz, Sylvia Weis, Mareike Franz, Frank Rominger, Oliver Trapp"]},"origin":[{"dateIssuedDisp":"2015","dateIssuedKey":"2015"}],"person":[{"family":"Walz","display":"Walz, Sarah","given":"Sarah","role":"aut"},{"family":"Weis","given":"Sylvia","display":"Weis, Sylvia","role":"aut"},{"given":"Mareike","display":"Franz, Mareike","family":"Franz","role":"aut"},{"role":"aut","family":"Rominger","given":"Frank","display":"Rominger, Frank"},{"display":"Trapp, Oliver","given":"Oliver","family":"Trapp","role":"aut"}],"relHost":[{"corporate":[{"role":"isb","display":"Electrophoresis Society"}],"origin":[{"publisherPlace":"Weinheim ; Weinheim","dateIssuedKey":"1980","dateIssuedDisp":"1980-","publisher":"Wiley-Blackwell ; Wiley-VCH"}],"title":[{"title_sort":"Electrophoresis","subtitle":"microfluids & proteomics","title":"Electrophoresis"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"36(2015), 5, Seite 796-804","volume":"36","year":"2015","pages":"796-804","extent":"9","issue":"5"},"id":{"zdb":["1475486-1"],"doi":["10.1002/(ISSN)1522-2683"],"issn":["1522-2683"],"eki":["26953878X"]},"note":["Gesehen am 10.03.09"],"disp":"Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatographyElectrophoresis","recId":"26953878X","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1980 -"]}],"note":["First published: 11 December 2014","Gesehen am 29.06.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1002/elps.201400499"],"eki":["1702838110"]},"physDesc":[{"extent":"9 S."}]} 
SRT |a WALZSARAHWINVESTIGAT2015